The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 113-123

  Rusciano, Maria Rosaria ^a   Salzano, Marcella ^a   Monaco, Sara ^a   Sapio, Maria Rosaria ^a   Illario, Maddalena ^a   De Falco, Valentina ^a   Santoro, Massimo ^a   Campiglia, Pietro ^b   Pastore, Lucio ^a,c   Fenzi, Gianfranco ^a   Rossi, Guido ^a   Vitale, Mario ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; 1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; B RAF KINASE; BRAF PROTEIN, HUMAN; CALMODULIN; ESTRANE DERIVATIVE; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 ((1 METHYLPIPERIDIN 4 YL)METHOXY)QUINAZOLIN 4 AMINE; N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYLPIPERIDIN-4-YL)METHOXY)QUINAZOLIN-4-AMINE; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN P21; PROTEIN RET; QUINAZOLINE DERIVATIVE; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; ONCOGENE RAS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA; AMINO ACID SEQUENCE; ANIMAL; CALCIUM SIGNALING; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; MOLECULAR GENETICS; MUTATION; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; RAT; THYROID TUMOR;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALMODULIN; CARCINOMA, PAPILLARY; CELL DIVISION; ENZYME ACTIVATION; ESTRENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; ONCOGENE PROTEIN P21(RAS); PIPERIDINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; PYRROLIDINONES; QUINAZOLINES; RATS; THYROID NEOPLASMS; TYPE C PHOSPHOLIPASES;

EID: 77449126326     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0214     Document Type: Article

References (29)

1. Arighi E, Alberti L, Torriti F, Ghizzoni S, Rizzetti MG, Pelicci G, Pasini B, Bongarzone I, Piutti C, Pierotti MA et al. 1997 Identification of Shc docking site on Ret tyrosine kinase. Oncogene 14 773-782.
2. Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P et al. 1996 The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. Molecular and Cellular Biology 16 2151-2163.
3. Castellone MD, Guarino V, De Falco V, Carlomagno F, Basolo F, Faviana P, Kruhoffer M, Orntoft T, Russell JP, Rothstein JL et al. 2004 Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23 5958-5967.
4. Chang BH, Mukherji S & Soderling TR 1998 Characterization of a calmodulin kinase II inhibitor protein in brain. PNAS 95 10890-10895.
5. Ciampi R & Nikiforov YE 2007 RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148 936-941.
6. Clapham DE 2007 Calcium signaling. Cell 131 1047-1058.
7. Demidenko ZN & Blagosklonny MV 2008 Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 7 3355-3361.
8. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW & Harris PE 1999 Prevalence of Ras mutations in thyroid neoplasia. Clinical Endocrinology 50 529-535.
9. Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C & Della Porta G 1992 TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene 7 237-242.
10. Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G & Vitale M 2003 Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. Journal of Biological Chemistry 278 45101-45108.
11. Illario M, Cavallo AL, Monaco S, Di Vito E, Mueller F, Marzano LA, Troncone G, Fenzi G, Rossi G & Vitale M 2005 Fibronectin-induced proliferation in thyroid cells is mediated by {alpha}v{beta}3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. Journal of Clinical Endocrinology and Metabolism 90 2865-2873.
12. Illario M, Monaco S, Cavallo AL, Esposito I, Formisano P, D'Andrea L, Cipolletta E, Trimarco B, Fenzi G, Rossi G et al. 2009 Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cellular Signalling 21 786-792.
13. Kelley GG, Reks SE, Ondrako JM & Smrcka AV 2001 Phospholipase C(epsilon): a novel Ras effector. EMBO Journal 20 743-754.
14. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE & Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research 63 1454-1457.
15. Knauf JA, Kuroda H, Basu S & Fagin JA 2003 RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22 4406-4412.
16. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T & Brabant G 2005 Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24 2144-2154.
17. Means AR 2000 Regulatory cascades involving calmodulin-dependent protein kinases. Molecular Endocinology 14 4-13.
18. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M et al. 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. Journal of Clinical Investigation 115 1068-1081.
19. Monaco S, Illario M, Rusciano MR, Gragnaniello G, Di Spigna G, Leggiero E, Pastore L, Fenzi G, Rossi G & Vitale M 2009 Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II. Cell Cycle 8 2024-2030.
20. Nikiforov YE 2002 RET/PTC rearrangement in thyroid tumors. Endocrine Pathology 13 3-16.
21. Richardson RM, Ali H, Pridgen BC, Haribabu B & Snyderman R 1998 Multiple signaling pathways of human interleukin-8 receptor A. Independent regulation by phosphorylation. Journal of Biological Chemistry 273 10690-10695.
22. Salvatore D, Barone MV, Salvatore G, Melillo RM, Chiappetta G, Mineo A, Fenzi G, Vecchio G, Fusco A & Santoro M 2000 Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. Journal of Clinical Endocrinology and Metabolism 85 3898-3907.
23. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G et al. 1996 Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12 1821-1826.
24. Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G & Vitale M 2006 Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). European Journal of Endocrinology 154 341-348.
25. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC et al. 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. Journal of Clinical Endocrinology and Metabolism 93 4331-4341.
26. Sherman SI 2003 Thyroid carcinoma. Lancet 361 501-511.
27. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y et al. 2007 A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nature Cell Biology 9 1273-1285.
28. Vitale M, Illario M, Di Matola T, Casamassima A, Fenzi G & Rossi G 1997 Integrin binding to immobilized collagen and fibronectin stimulates the proliferation of human thyroid cells in culture. Endocrinology 138 1642-1648.
29. Zlotnik A & Yoshie O 2000 Chemokines: a new classi-fication system and their role in immunity. Immunity 12 121-127.